SCHEMBL3104083

SCHEMBL3104083

CCOC(=O)COc1cc(Cl)c(Nc2nc(COC)nc(OC)c2[N+](=O)[O-])cc1OCc1c(F)cccc1OC

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
KDR P35968 3/20 0.35
ERBB2 P04626 1/20 0.35
EPHA2 P29317 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
PDE10A Q9Y233 1/20 0.34
TDP1 Q9NUW8 1/20 0.33
CNR2 P34972 1/20 0.33
MAPT P10636 3/20 0.32
LMNA P02545 2/20 0.32
EGFR P00533 1/20 0.32
GPR119 Q8TDV5 1/20 0.32
MAPK1 P28482 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
S1PR4 O95977 1/20 0.32
ALDH1A1 P00352 1/20 0.32
ITGA4 P13612 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3109489 0.84 NPC1 (0.38) NPC1RAB9AKDRMEN1KMT2A
SCHEMBL3100361 0.82 KDR (0.43) KDRERBB2EPHA2MAPTEGFR
SCHEMBL3107334 0.82 NPC1 (0.36) NPC1RAB9AKDRCNR2MAPT
SCHEMBL3311050 0.78
SCHEMBL3311045 0.76
SCHEMBL3099996 0.76 KDR (0.35) NPC1RAB9AKDRMAPTLMNA
SCHEMBL3094188 0.74 KMT2A (0.40) MEN1KMT2APDE10AMAPTMAPK1
SCHEMBL3094177 0.73 NPC1 (0.39) NPC1RAB9AKDRMEN1KMT2A
SCHEMBL3116232 0.73 NPC1 (0.36) NPC1RAB9AKDRMEN1KMT2A
SCHEMBL3105309 0.73 EGFR (0.37) KDRERBB2EPHA2MAPTEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2143724-B1 NITROGENATED FUSED RING DERIVATIVE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, AND USE OF THE SAME FOR MEDICAL PURPOSES KISSEI PHARMACEUTICAL (JP) 2013-12-11 EP disclosed
EP-2143724-A1 NITROGENATED FUSED RING DERIVATIVE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, AND USE OF THE SAME FOR MEDICAL PURPOSES Kissei Pharmaceutical Co., Ltd. (JP) 2010-01-13 EP disclosed